ZIOP (Ziopharm Oncology IN) stock is currently covered by 5 analysts. The average analyst rating is 3.2 out of 5.
ZIOP analysts have given it a high price target of $6, mean price target of $5.5, and a low price target of $5.
ZIOP currently has an estimated 12-Month price forecast of $5.5 based on the average analyst price target.
[wpdatatable id=10 var1=ZIOP]